# Viemed Healthcare, Inc.: filings

VMD · Nasdaq · CIK 1729149 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vmd.md) · [Financials](/companies/vmd/financials.md) · [Filings](/companies/vmd/filings.md) · [Insiders](/companies/vmd/insiders.md)

## Reports and events: 132 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 173, 8-K 91, 10-Q 22, 4/A 19, 3 13, SC 13G/A 11, 3/A 10, SC 13G 10, 10-K 7, DEF 14A 6, DEFA14A 6, S-8 6, CORRESP 5, SCHEDULE 13G/A 5, 144 3, ARS 3, UPLOAD 3, EFFECT 2, S-3 2, SC 13D/A 2, SCHEDULE 13G 2, 10-12B 1, 10-12B/A 1, 10-K/A 1, 8-K/A 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, SC 13D 1, SCHEDULE 13D/A 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 17:22 ET | [SCHEDULE 13D/A](/filings/0001781905-26-000019.md) | Ownership report, active investor, amended | 0001781905-26-000019 |
| 2026-08-20 | 17:03 ET | [8-K](/filings/0001729149-26-000048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000048 |
| 2026-08-03 | 17:04 ET | [10-Q](/filings/0001729149-26-000042.md) | Quarterly report, period 2026-06-30 | 0001729149-26-000042 |
| 2026-08-03 | 17:01 ET | [8-K](/filings/0001729149-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-26-000041 |
| 2026-06-04 | 16:07 ET | [8-K](/filings/0001729149-26-000034.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-26-000034 |
| 2026-06-02 | 17:00 ET | [8-K](/filings/0001729149-26-000032.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000032 |
| 2026-05-05 | 17:02 ET | [10-Q](/filings/0001729149-26-000029.md) | Quarterly report, period 2026-03-31 | 0001729149-26-000029 |
| 2026-05-05 | 17:00 ET | [8-K](/filings/0001729149-26-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-26-000028 |
| 2026-04-22 | 16:45 ET | [DEF 14A](/filings/0001729149-26-000022.md) | Proxy statement, period 2026-04-22 | 0001729149-26-000022 |
| 2026-03-16 | 16:51 ET | [8-K](/filings/0001729149-26-000011.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000011 |
| 2026-03-04 | 16:50 ET | [10-K](/filings/0001729149-26-000009.md) | Annual report, period 2025-12-31 | 0001729149-26-000009 |
| 2026-03-04 | 16:47 ET | [8-K](/filings/0001729149-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-26-000008 |
| 2025-11-07 | 16:02 ET | [8-K](/filings/0001729149-25-000151.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001729149-25-000151 |
| 2025-11-05 | 16:40 ET | [10-Q](/filings/0001729149-25-000149.md) | Quarterly report, period 2025-09-30 | 0001729149-25-000149 |
| 2025-11-05 | 16:38 ET | [8-K](/filings/0001729149-25-000148.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000148 |
| 2025-09-23 | 17:01 ET | [8-K](/filings/0001729149-25-000142.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-25-000142 |
| 2025-08-06 | 17:06 ET | [10-Q](/filings/0001729149-25-000119.md) | Quarterly report, period 2025-06-30 | 0001729149-25-000119 |
| 2025-08-06 | 17:04 ET | [8-K](/filings/0001729149-25-000118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000118 |
| 2025-07-02 | 08:46 ET | [8-K](/filings/0001729149-25-000112.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000112 |
| 2025-06-09 | 08:12 ET | [8-K](/filings/0001729149-25-000101.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-25-000101 |
| 2025-06-05 | 17:15 ET | [8-K](/filings/0001729149-25-000098.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-25-000098 |
| 2025-05-07 | 16:50 ET | [10-Q](/filings/0001729149-25-000096.md) | Quarterly report, period 2025-03-31 | 0001729149-25-000096 |
| 2025-05-07 | 16:47 ET | [8-K](/filings/0001729149-25-000095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000095 |
| 2025-05-06 | 08:34 ET | [8-K](/filings/0001729149-25-000086.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000086 |
| 2025-04-25 | 08:45 ET | [DEF 14A](/filings/0001729149-25-000079.md) | Proxy statement, period 2025-04-25 | 0001729149-25-000079 |
| 2025-04-14 | 16:29 ET | [8-K](/filings/0001729149-25-000067.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001729149-25-000067 |
| 2025-03-18 | 16:26 ET | [8-K](/filings/0001729149-25-000062.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000062 |
| 2025-03-10 | 17:08 ET | [10-K](/filings/0001729149-25-000056.md) | Annual report, period 2024-12-31 | 0001729149-25-000056 |
| 2025-03-10 | 17:03 ET | [8-K](/filings/0001729149-25-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000055 |
| 2024-11-12 | 08:04 ET | [8-K](/filings/0001729149-24-000213.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000213 |
| 2024-11-06 | 16:48 ET | [10-Q](/filings/0001729149-24-000210.md) | Quarterly report, period 2024-09-30 | 0001729149-24-000210 |
| 2024-11-06 | 16:47 ET | [8-K](/filings/0001729149-24-000209.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000209 |
| 2024-08-14 | 16:53 ET | [8-K](/filings/0001729149-24-000170.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000170 |
| 2024-08-07 | 17:06 ET | [10-Q](/filings/0001729149-24-000162.md) | Quarterly report, period 2024-06-30 | 0001729149-24-000162 |
| 2024-08-07 | 17:02 ET | [8-K](/filings/0001729149-24-000160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000160 |
| 2024-06-06 | 17:24 ET | [8-K](/filings/0001729149-24-000152.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-24-000152 |
| 2024-05-29 | 17:11 ET | [8-K](/filings/0001729149-24-000148.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001729149-24-000148 |
| 2024-05-09 | 17:24 ET | [8-K](/filings/0001729149-24-000123.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000123 |
| 2024-05-06 | 17:04 ET | [10-Q](/filings/0001729149-24-000102.md) | Quarterly report, period 2024-03-31 | 0001729149-24-000102 |
| 2024-05-06 | 17:02 ET | [8-K](/filings/0001729149-24-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000101 |
| 2024-04-26 | 09:08 ET | [DEF 14A](/filings/0001729149-24-000096.md) | Proxy statement, period 2024-04-26 | 0001729149-24-000096 |
| 2024-04-02 | 09:07 ET | [8-K](/filings/0001729149-24-000088.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000088 |
| 2024-03-11 | 16:47 ET | [8-K](/filings/0001729149-24-000079.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000079 |
| 2024-03-06 | 17:09 ET | [10-K](/filings/0001729149-24-000077.md) | Annual report, period 2023-12-31 | 0001729149-24-000077 |
| 2024-03-06 | 17:04 ET | [8-K](/filings/0001729149-24-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000075 |
| 2024-02-15 | 09:27 ET | [SC 13D/A](/filings/0001781905-24-000002.md) | Ownership report, active investor, amended | 0001781905-24-000002 |
| 2023-12-07 | 09:02 ET | [8-K](/filings/0001729149-23-000170.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001729149-23-000170 |
| 2023-11-08 | 17:38 ET | [8-K](/filings/0001729149-23-000164.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000164 |
| 2023-11-01 | 17:03 ET | [10-Q](/filings/0001729149-23-000161.md) | Quarterly report, period 2023-09-30 | 0001729149-23-000161 |
| 2023-11-01 | 17:01 ET | [8-K](/filings/0001729149-23-000160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000160 |

Page 1 of 3. [Older](/companies/vmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.